Join Growin Stock Community!

暄達7726.TW Overview

TW StockBiotech. & Medical
(No presentation for 7726)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

暄達（7726）Overall Performance

暄達（7726）AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

暄達（7726） PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

暄達（7726）Key Information

暄達（7726）Profile

Carilex Medical, Inc. engages in the manufacturing of medical devices to prevent pressure ulcers and wound care management. Its products include medical grade air beds, chair cushion and negative pressure wound treatment machine. The company was founded on May 23, 2012 and is headquartered in Taoyuan, China.

暄達（7726）FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

default symbol

7726

暄達

38.30D

0.00%

(0.00)

  • When is 7726's latest earnings report released?

    The most recent financial report for 暄達 (7726) covers the period of 2025Q2 and was published on 2025/06/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 7726's short-term business performance and financial health. For the latest updates on 7726's earnings releases, visit this page regularly.

  • How much cash does 7726 have?

    At the end of the period, 暄達 (7726) held Total Cash and Cash Equivalents of 160.21M, accounting for 0.36 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 7726 go with three margins increasing?

    In the latest report, 暄達 (7726) did not achieve the “three margins increasing” benchmark, with a gross margin of 48.91%%, operating margin of 2.98%%, and net margin of -6.97%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 7726's profit trajectory and future growth potential.

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
1.87
PE Ratio (TTM)
20.47
Forward PE
-
PS Ratio (TTM)
0.99
PB Ratio
2.53
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
43.06%
Net Margin
4.83%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
1.87
PE Ratio (TTM)
20.47
Forward PE
-
PS Ratio (TTM)
0.99
PB Ratio
2.53
Price-to-FCF
-
Gross Margin
43.06%
Net Margin
4.83%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%